GPS, BAT, MNC pharmaceutical companies... The Giants' deep-dive industrial layout Of AI Medical Nuggets is heating up.

Guide: Multinational pharmaceutical companies focus on new drug research and development or work together or self-built platform In recent years, the continuous breakthrough of new technology has brought a lot of convenient way of life from offline to online, especially the impact of the epidemic makes the Internet, and other modern technology penetrate into all aspects of lifeIn the medical field is a scent of medical companies in addition to attracting the attention of traditional medical companies there are many Internet companies to this eyeThe medical device trio continue to expand from products to service device manufacturers are well suited to medical careOn the one hand, the equipment base owned by the device manufacturer facilitates the acquisition of dataOn the other hand, the device manufacturers have a more mature medical sales channels(:Philips, Siemens Medical) as the three major medical devices with the advancement of China's medical reform actively conform to the trend of science and technology layout, including robotics, imaging, auxiliary diagnosis, including a number of medical fields to build their own artificial intelligence ecologyIn the year it spun off its medical business and independently established a medical company focused on digital medical applications and solutions to launch a cloud-based cardiac magnetic resonance assistance diagnostic systemChen Jinlei, vice president of Medical China, said in an interview that in the future, Healthcare will focus more on the needs of users and actively develop new digital application service users will also explore the complete solution path through the integration of multi-algorithmsolution suitesPhilips and Siemens share similar transformational ideas that will expand digital from product production to serviceA key product introduced by Philips in the medical digitalization process- Nebula Medical Imaging Artificial Intelligence Platform connects customers and patients with "production, learning, research" in the context of practical applications through the Philips Nebula 3D Image After Processing Platform ()) and the Philips Nebula Discovery Platform ()This is similar to a complete workstation that allows businesses to develop better, more efficient and convenient smart solutions that provide the foundation for Philips Healthcare to build its own ai-based ecosystemSiemens Healthcare's strategy is a step-by-step process: first, to embed artificial intelligence into the company's existing equipment products, then to provide solutions based on data, and finally to explore data-based applicationsSiemens products are similar to Apple's "" is a holistic solution to the problem of standardizationIt is understood that medical care, Philips will continue to invest more than one billion dollars in research and development each yearPhilips spends up to 100 million euros a year on research and development, including software and technology developmentMultinational pharmaceutical companies focus on new drug research and development or work together or build their own platform compared to the medical device giant multinational pharmaceutical companies in the field of science and technology slightly inferiorIn the trend of medical care in order to get a piece of the market as early as possible most of the choice of technology development mature enterprises hand in hand by outsourcing the form of research and development beyond the new drug research and development "double ten fatalism" (the research and development cycle exceeds the annual research and development costs of more than 100 million Dollars) the problem Research and development outsourcing is mainly modeled by pharmaceutical companies that provide research data and bio-target information technology companies When a candidate drug is successfully screened out, the pharmaceutical company will license or own the drug in accordance with the agreement, which is highly flexible and less costly Since then, the application in the pharmaceutical field is in full swing international pharmaceutical giants have been in the development of the bureau From the table above, the outsourcing of drug research and development in recent years mainly utilizes the data algorithm technology of technology companies focused on the field of new target discovery and small molecule drug research and development Of course, there is no shortage of pharmaceutical companies in the enterprise to form research and development departments in the enterprise in active external cooperation at the same time to develop in-house professional skills and establish digital infrastructure to improve data efficiency Earlier, Novartis completed the in-house digital transformation strategy, which focused on building big data, digital foundations and systems for document management, internal investigations, high-performance computing, and clinical trial management The next step will be to implement a predictive analytics platform driven by machine learning algorithms to support clinical trial operations The difficulty of digital transformation of traditional pharmaceutical companies' self-built technology platform is self-evident In response to this challenge, a number of public cloud service providers have emerged in recent years to facilitate the self-built technology platforms of pharmaceutical companies Mercado is the latest cloud precision medical platform to be developed with cloud services that provides a collaborative environment using open-built analytics platforms to accelerate early development of targeted treatment for patients Internet capital to help slow disease management to develop medical products in addition to traditional medical giants technology capital giants are also very concerned about the medical field Especially combined with the current situation of aging and the head drug companies cooperative layout of slow disease management has become one of the main forms of Internet companies into the medical system Compared with the drug, arms suppliers Internet enterprises the biggest advantage is the powerful role of the end Tencent and Lilly reached a partnership to promote diabetes solutions Late last year, Tencent and Novartis launched the country's first artificial intelligence disease management platform for heart disease, Care For Love In addition, Ali, JD.com is not willing to lag behind the action frequency Last year, Ali Health and Pfizer signed a strategic partnership to cooperate in drug traceability, smart medicine and other areas to gradually explore drug safety, patient education and other areas of in-depth research JD.com also launched three new programs, including "New Slow Disease Prevention and Control", last year, to collaborate with Novartis on the online community of the Alzheimer's Patient Shack and reached a cooperation with Weishi China early last month on the online service of medical and health services for the elderly population With the help of its own platform characteristics, advantages of the Internet technology and strong capital force can also independently develop their own medical products In the year and year Baidu and Ali have launched their own "medical brain." Ali Health also released its medical products In the same year, the Ministry of Science and Technology announced the first batch of national ai-artificial intelligence open innovation platform list can be found that Tencent has been designated as the builder of medical imaging platform Not long ago, Tencent launched a cloud-deep-intelligence drug platform for drug research and development The investment field of healthcare has been the focus of continued attention from large factories It is worth noting that compared with other Internet companies in the direction of Baidu is committed to the medical sector investment total investment amount has now reached 100 million yuan On last month Baidu invested more than 100 million yuan to hand in hand with East Soft Layout Medical Due to Ali, Tencent layout medical time earlier and has many years of deep experience in hospitals, doctors and other resources and relying on their own technology, financial advantages continue to expand the industry service boundary will be in a long-term leading position But JD.com's strong explosive power as a post-entry is also a strong competitor to the market In the domestic medical market predators have now gathered in medical, science and technology and other multi-capital their different genetic advantages are different from multi-party cooperation or single-minded girder industry ecology finally present waiting time to give us a reply Related: Titanium Media: Medical Battlefield Narrow Road Meets the Big Three's New Story Medicine Ferry: Talking About Artificial Intelligence () Driven New Drug Research and Development Giant Enters the Internet Medical Industry Ushering in a New Era of Development? Baidu hand-in-hand with the East Soft to speed up the medical layout.